The association between CD133 and tumor grade was tested in the combined cohort (with only five cohorts, omitting GSE7696) by Chi-Square analysis, and we found a significant correlation between CD133 expression and tumor grade (Figure 2; p < 0.001). The gene discussed is PROM1; the disease is neoplasm.